Sheng-Mai-Yin inhibits doxorubicin-induced ferroptosis and cardiotoxicity through regulation of Hmox1

Doxorubicin (DOX) is a potent chemotherapeutic drug used for treating various cancers. However, its clinical use is limited due to its severe cardiotoxicity, which often results in high mortality rates. Sheng-Mai-Yin (SMY), a Traditional Chinese medicine (TCM) prescription, has been reported to exer...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Peina, Chen, Zhaoyang, Sun, Tianhui, Wu, Lili, Wang, Yifan, Guo, Tianwei, Yang, Jin, Zhu, Jiebin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599746/
https://www.ncbi.nlm.nih.gov/pubmed/37770231
http://dx.doi.org/10.18632/aging.205062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599746/
https://www.ncbi.nlm.nih.gov/pubmed/37770231
http://dx.doi.org/10.18632/aging.205062

Ejemplares similares